Dr. Posadas named director of Cedars-Sinai GU oncology program

Article

Edwin Posadas, MD, has joined Cedars-Sinai Medical Center, Los Angeles, as the clinical director of the genitourinary medical oncology program in the Samuel Oschin Comprehensive Cancer Institute.

Edwin Posadas, MD, has joined Cedars-Sinai Medical Center, Los Angeles, as the clinical director of the genitourinary medical oncology program in the Samuel Oschin Comprehensive Cancer Institute.

In his research, Dr. Posadas has focused on mechanisms through which cancer cells in localized tumors spread. In upcoming studies at Cedars-Sinai, he will work to define the protein FYN’s function in prostate cancer cells, with the goal of applying his basic science findings to developing new therapies to benefit men with advanced prostate cancer.

"Dr. Posadas is an innovative researcher focused on finding effective ways to treat cancer and stop it from spreading," said Steven Piantadosi, MD, PhD, director of the Samuel Oschin Comprehensive Cancer Institute and Phase One Foundation Chair. "His understanding of the molecular mechanisms of cancer growth may well lead to targeted therapies that stop cancer cells from gaining footholds in other organs, essentially keeping the disease contained and manageable."

Related Videos
Daniel J. Heidenberg, MD, answers a question during a Zoom video interview
African American patient explaining issues to Asian doctor using tablet | Image Credit: © rocketclips - stockadobe.com
Todd M. Morgan, MD, answers a question during a Zoom video interview
3D illustration of prostate cancer cells | Image Credit: © Dr_Microbe - stock.adobe.com
Group of doctors reading a document | Image Credit: © Flamingo Images - stock.adobe.com
Brian T. Helfand, MD, and Matthew Smith, MD, PhD, experts on prostate cancer
Related Content
© 2024 MJH Life Sciences

All rights reserved.